What is Rachel Gurrieri's NPI number?

Rachel Gurrieri's National Provider Identifier (NPI) is 1467068171, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.

What is Rachel Gurrieri's specialty?

Rachel Gurrieri is listed in the NPPES registry with a primary specialty of Physician Assistant (Physician Assistants & Advanced Practice Nursing Providers).

Where is Rachel Gurrieri located?

Rachel Gurrieri's practice location on file with NPPES is 400 W Main St Ste 211, Babylon, NY 11702-3009.

What is Rachel Gurrieri's phone number?

The practice phone number listed in the NPPES registry for Rachel Gurrieri is (631) 295-5450.

Does Rachel Gurrieri accept Medicare?

Rachel Gurrieri is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.

Is Rachel Gurrieri's NPI active?

Yes — Rachel Gurrieri's NPI (1467068171) is active in the NPPES registry as of the last update on 2024-04-17.

IndividualActiveAccepts Medicare

Rachel Gurrieri, PA-C

NPI 1467068171 · Physician Assistant · Babylon, NY

Rachel Gurrieri, PA-C is a Physician Assistant provider in Babylon, NY (NPI 1467068171).

Provider details

NPI number: 1467068171
Entity type: Individual
Primary specialty: Physician AssistantPhysician Assistants & Advanced Practice Nursing Providers
Credential: PA-C
Sex: Female
Sole proprietor: No
License: 025728 (NY)

Practice location

400 W Main St Ste 211

Babylon, NY 11702-3009

Phone: (631) 295-5450

Fax: (631) 295-5451

Street-level locationGet directions

More NY providers

Mailing address

400 W Main St Ste 211

Babylon, NY 11702-3009

Specialties & taxonomies

Physician AssistantPrimary363A00000XLicense 025728 (NY)
Physician Assistants & Advanced Practice Nursing Providers

Enrolled with Medicare as Practitioner - Physician Assistant · source: CMS PECOS Public Provider Enrollment (2026.04.01)

Profile Score

Established profile(69/100 index)

A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.

Registry tenure33% of score
6 yrs in NPPES registry
Profile completeness33% of score
100% of core fields populated
Practice footprint20% of score
1 documented practice location
Open Payments transparency13% of score
Has Open Payments disclosures (2024)

Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	138	$6
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	74	$85
New Patient Office Or Other Outpatient Visit With Low Level of Medical Decision Making, If Using Time, 30 Minutes Or More99203	44	$104
Destruction of Precancer Skin Growth, 1 Growth17000	42	$55
Biopsy of Related Skin Growth, First Growth11102	36	$96
Established Patient Office Or Other Outpatient Visit With Straightforward Medical Decision Making, If Using Time, 10 Minutes Or More

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 9 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Ketoconazole	44	22
Triamcinolone Acetonide	43	36
Mupirocin	30	26
Clobetasol Propionate	24	12
Ammonium Lactate	13	—
Efinaconazolebrand: Jublia	13	—
Hydrocortisone	12	12
Dupilumabbrand: Dupixent Pen

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$2,518 across 83 records (Open Payments 2024)

Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.

Enumerated: 2020-09-17
Last updated: 2024-04-17
Certified: 2024-03-06

Frequently asked questions

What is Rachel Gurrieri's NPI number?: Rachel Gurrieri's National Provider Identifier (NPI) is 1467068171, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
What is Rachel Gurrieri's specialty?: Rachel Gurrieri is listed in the NPPES registry with a primary specialty of Physician Assistant (Physician Assistants & Advanced Practice Nursing Providers).
Where is Rachel Gurrieri located?: Rachel Gurrieri's practice location on file with NPPES is 400 W Main St Ste 211, Babylon, NY 11702-3009.
What is Rachel Gurrieri's phone number?: The practice phone number listed in the NPPES registry for Rachel Gurrieri is (631) 295-5450.
Does Rachel Gurrieri accept Medicare?: Rachel Gurrieri is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
Is Rachel Gurrieri's NPI active?: Yes — Rachel Gurrieri's NPI (1467068171) is active in the NPPES registry as of the last update on 2024-04-17.

Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	138	$6
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	74	$85
New Patient Office Or Other Outpatient Visit With Low Level of Medical Decision Making, If Using Time, 30 Minutes Or More99203	44	$104
Destruction of Precancer Skin Growth, 1 Growth17000	42	$55
Biopsy of Related Skin Growth, First Growth11102	36	$96
Established Patient Office Or Other Outpatient Visit With Straightforward Medical Decision Making, If Using Time, 10 Minutes Or More

Drug

Part D claims (2024)

Beneficiaries

Ketoconazole

Triamcinolone Acetonide

Mupirocin

Clobetasol Propionate

Ammonium Lactate

—

Efinaconazolebrand: Jublia

—

Hydrocortisone

Dupilumabbrand: Dupixent Pen

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$2,518 across 83 records (Open Payments 2024)

Provider details

Practice location

Mailing address

Specialties & taxonomies

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments

Registry dates

Frequently asked questions

Specialties & taxonomies

Frequently asked questions

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments